{"url_path":"/fda/drug/recalls/D-0725-2026","section_key":"summary","section_title":"DRUG Recall: Fresenius Kabi USA, LLC — Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x  5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial:  63323-578-07","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-16","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0725-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Fresenius Kabi USA, LLC"},"word_count":94,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0725-2026\n\n**Recalling firm:** Fresenius Kabi USA, LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-16\n**Report date:** 2026-07-29\n\n## Product\nGlycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x  5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial:  63323-578-07\n\n## Reason\nPresence of Particulate Matter: Hair was found in product\n\n## Affected lots\nLot #: 6134349, 6134620 Exp. Date 11/2026\n\n## Distribution\nNationwide within in the USA"}